Loading...
AIRS logo

AirSculpt Technologies, Inc.NasdaqGM:AIRS 주식 보고서

시가총액 US$371.1m
주가
US$5.33
US$6
11.2% 저평가 내재 할인율
1Y25.4%
7D11.0%
1D
포트폴리오 가치
​
보기

AirSculpt Technologies, Inc.

NasdaqGM:AIRS 주식 리포트

시가총액: US$371.1m

AirSculpt Technologies (AIRS) 주식 개요

는 자회사와 함께 미국과 캐나다에서 바디 컨투어링 시술 서비스를 제공하는 EBS Intermediate Parent LLC의 지주회사로서 운영에 주력하고 있습니다. 자세히 보기

AIRS 펀더멘털 분석
스노우플레이크 점수
가치 평가0/6
미래 성장0/6
과거 실적0/6
재무 건전성3/6
배당0/6

위험 분석

지난 3개월 동안 주가 변동성이 US 시장과 비교했을 때 매우 높았습니다.

지난 1년 동안 주주가 희석되었습니다.

현재 수익성이 없으며 향후 3년 동안 수익을 낼 것으로 예상되지 않습니다.


AIRS Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Analyst Price Targets

View all narratives

AirSculpt Technologies, Inc. 경쟁사

가격 이력 및 성과

AirSculpt Technologies 주가의 최고가, 최저가 및 변동 요약
과거 주가
현재 주가US$5.33
52주 최고가US$12.00
52주 최저가US$1.51
베타2.02
1개월 변동98.88%
3개월 변동183.51%
1년 변동25.41%
3년 변동-29.22%
5년 변동n/a
IPO 이후 변동-66.46%

최근 뉴스 및 업데이트

Recent updates

분석 기사 • Jan 06

AirSculpt Technologies, Inc.'s (NASDAQ:AIRS) Share Price Is Still Matching Investor Opinion Despite 35% Slump

Unfortunately for some shareholders, the AirSculpt Technologies, Inc. ( NASDAQ:AIRS ) share price has dived 35% in the...
Seeking Alpha • Oct 29

AirSculpt Technologies: Upgrading To Buy On Improving Fundamentals

Summary Upgrade AirSculpt Technologies (AIRS) to 'Buy' as strong technical momentum and record lead generation drive optimism for further upside. AIRS delivered positive sequential growth in Q2, with improved gross margins, reduced SG&A expenses, and lower customer acquisition costs supporting profitability. Debt reduction and the highest operating cash flow in eight quarters position AIRS closer to sustained profitability, despite macro risks and elevated valuation. Q3 earnings are critical; AIRS must meet or exceed $39.8 million in revenue to maintain momentum and justify its premium sales multiple. Read the full article on Seeking Alpha
분석 기사 • Oct 05

AirSculpt Technologies, Inc.'s (NASDAQ:AIRS) Shares Climb 32% But Its Business Is Yet to Catch Up

Despite an already strong run, AirSculpt Technologies, Inc. ( NASDAQ:AIRS ) shares have been powering on, with a gain...
분석 기사 • Sep 24

Estimating The Intrinsic Value Of AirSculpt Technologies, Inc. (NASDAQ:AIRS)

Key Insights AirSculpt Technologies' estimated fair value is US$7.56 based on 2 Stage Free Cash Flow to Equity...
분석 기사 • Aug 29

Here's Why AirSculpt Technologies (NASDAQ:AIRS) Can Afford Some Debt

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
분석 기사 • Jul 25

AirSculpt Technologies, Inc.'s (NASDAQ:AIRS) 28% Share Price Surge Not Quite Adding Up

Despite an already strong run, AirSculpt Technologies, Inc. ( NASDAQ:AIRS ) shares have been powering on, with a gain...
분석 기사 • Jun 10

AirSculpt Technologies, Inc.'s (NASDAQ:AIRS) Shares Climb 69% But Its Business Is Yet to Catch Up

The AirSculpt Technologies, Inc. ( NASDAQ:AIRS ) share price has done very well over the last month, posting an...
분석 기사 • Apr 25

Some Confidence Is Lacking In AirSculpt Technologies, Inc. (NASDAQ:AIRS) As Shares Slide 31%

To the annoyance of some shareholders, AirSculpt Technologies, Inc. ( NASDAQ:AIRS ) shares are down a considerable 31...
분석 기사 • Feb 25

AirSculpt Technologies, Inc.'s (NASDAQ:AIRS) Share Price Matching Investor Opinion

It's not a stretch to say that AirSculpt Technologies, Inc.'s ( NASDAQ:AIRS ) price-to-sales (or "P/S") ratio of 1.4x...
분석 기사 • Jan 28

Investors Could Be Concerned With AirSculpt Technologies' (NASDAQ:AIRS) Returns On Capital

Ignoring the stock price of a company, what are the underlying trends that tell us a business is past the growth phase...
분석 기사 • Dec 04

An Intrinsic Calculation For AirSculpt Technologies, Inc. (NASDAQ:AIRS) Suggests It's 40% Undervalued

Key Insights Using the 2 Stage Free Cash Flow to Equity, AirSculpt Technologies fair value estimate is US$12.46 Current...
분석 기사 • Nov 14

Why Investors Shouldn't Be Surprised By AirSculpt Technologies, Inc.'s (NASDAQ:AIRS) 30% Share Price Surge

Despite an already strong run, AirSculpt Technologies, Inc. ( NASDAQ:AIRS ) shares have been powering on, with a gain...
분석 기사 • Nov 07

Is AirSculpt Technologies (NASDAQ:AIRS) A Risky Investment?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
분석 기사 • Oct 20

The Return Trends At AirSculpt Technologies (NASDAQ:AIRS) Look Promising

There are a few key trends to look for if we want to identify the next multi-bagger. Ideally, a business will show two...
분석 기사 • Sep 28

Optimistic Investors Push AirSculpt Technologies, Inc. (NASDAQ:AIRS) Shares Up 29% But Growth Is Lacking

AirSculpt Technologies, Inc. ( NASDAQ:AIRS ) shareholders have had their patience rewarded with a 29% share price jump...
분석 기사 • Sep 25

Is It Time To Consider Buying AirSculpt Technologies, Inc. (NASDAQ:AIRS)?

AirSculpt Technologies, Inc. ( NASDAQ:AIRS ), might not be a large cap stock, but it saw a significant share price rise...
분석 기사 • Aug 01

The Market Lifts AirSculpt Technologies, Inc. (NASDAQ:AIRS) Shares 26% But It Can Do More

Those holding AirSculpt Technologies, Inc. ( NASDAQ:AIRS ) shares would be relieved that the share price has rebounded...
분석 기사 • Apr 04

There's Been No Shortage Of Growth Recently For AirSculpt Technologies' (NASDAQ:AIRS) Returns On Capital

What are the early trends we should look for to identify a stock that could multiply in value over the long term...
분석 기사 • Feb 23

Here's Why AirSculpt Technologies (NASDAQ:AIRS) Can Manage Its Debt Responsibly

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...
분석 기사 • Dec 14

AirSculpt Technologies, Inc. (NASDAQ:AIRS) Stocks Shoot Up 31% But Its P/S Still Looks Reasonable

AirSculpt Technologies, Inc. ( NASDAQ:AIRS ) shareholders are no doubt pleased to see that the share price has bounced...
분석 기사 • Nov 12

US$8.19: That's What Analysts Think AirSculpt Technologies, Inc. (NASDAQ:AIRS) Is Worth After Its Latest Results

There's been a notable change in appetite for AirSculpt Technologies, Inc. ( NASDAQ:AIRS ) shares in the week since its...
분석 기사 • Sep 20

Be Wary Of AirSculpt Technologies (NASDAQ:AIRS) And Its Returns On Capital

When we're researching a company, it's sometimes hard to find the warning signs, but there are some financial metrics...
분석 기사 • Oct 29

Capital Allocation Trends At AirSculpt Technologies (NASDAQ:AIRS) Aren't Ideal

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Ideally, a...
Seeking Alpha • Aug 27

AirSculpt Technologies: Niche Offering Offset By Profitability, Valuation

Summary AirSculpt Technologies presents with a unique offering with exposure to alternative medical sectors in cosmetics. The company's growth strategy is well received but comes with notable execution risks. Shares appear to be reasonably valued at current levels, however, deeper examination of financials places questions on just what we are buying. With these points in mind, we value AIRS a hold. Investment summary AirSculpt Technologies, Inc. (AIRS) has piqued our interest since listing back in FY21. It operates in a novel segment of 'body contouring procedures' and is best known for its AirSculpt procedure, under the subsidiary brand Elite Body Sculpture. The proprietary procedure is touted due to its minimally invasive nature that contrasts to traditional liposuction. Its growth strategy is to open new centres and expand/relocate existing ones, ultimately driving up revenue per case, cases per room and overall case numbers as part of its growth strategy. Exhibit 1. AIRS 6-month price action Data: Refinitiv Eikon Despite the allure, forensics over its financial statements reveal there to be a loose fit to the kind of equity premia we are seeking exposure to in H2 FY22. Valuations are supportive of a neutral view and regulatory headwinds in adjacent markets [Australia, to be specific] has us cautious on the ramifications for global peers. With these points in mind, we rate AIRS a hold. Q2 earnings indicate growth trends We see the differentiated strengths of AIRS' procedures in its most recent earnings, with upsides to consensus at the top and bottom lines. Forecasts on the global cosmetic market growth published in April 2022 predict a geometric growth of 3.6% per year from 2021 until 2028. Contrary evidence suggests a 9.6% CAGR into 2030. AIRS printed revenue of $49.7 million for the period, up 42% YoY. Presuming either of the above forecasts are true, then AIRS above top-line growth suggest it gained additional market share during the quarter. As a side note, however, this is a murky segment - recent controversies in the Australian cosmetic surgery market surrounding regulation are a potential risk for global participants. Cases also increased 22.5% YoY to 3,691 total cases, as seen in Exhibit 2. The company records each case as 1 visit, with doesn't factor in that each patient may have multiple treatment areas per visit. Nevertheless, it opened 4 new centres during Q2 FY21, bringing total centres to 19. Meanwhile, revenue per case increased 16% YoY to ~$13,450, supported by the company's access to 38 procedure rooms versus 25 the year prior. However, the 10-Q did note that cases per procedure room declined due to the addition of the 13 new centres and expansion of existing ones, versus an organic decline over the 12 months. There is good reason to estimate that trends will normalize as procedures per room level to overall company growth trends. Exhibit 2. Above-market growth statistics imply the company might be gaining additional market share Image: HB Insights, AIRS SEC Filings Despite the upsides in booked revenues for the quarter, our findings indicate there are drains and pulls on liquidity that may place stress on AIRS' current position. As seen below, we estimate there to be around 3-4 quarters of cash runway remaining with the company's most recent earnings. It needs a substantial growth in cash conversion from net income to bolster its position here and prevent additional dilutive equity raise(s) and/or expensive debt issuance/origination in the high yield debt capital markets. Noteworthy to this point, however, is the company declared a $0.41/share special dividend to be paid in September. Exhibit 3. Data: HB Insights Estimates The company also reports non-GAAP EBITDA and recorded a $1.01 million YoY increase to $15.2 million as seen in Exhibit 4. This is despite earnings narrowing by 94% YoY from ~$10 million to $583,000. According to the 10-Q, "management assesses and believes investors should assess our operating performance" [using non-GAAP EBITDA]. We take some issue with this recommendation. Firstly, the company booked ~$7.3 million in stock-based compensation ("SBC") for the period, and saw an interest expense of $1.5 million - each up substantially on the year. Moreover, as seen below, AIRS asks us to ignore the impact of new centre opening and relocation costs, plus the SBC, plus the loss on asset disposals. We argue these are expenses that must be realized in the analysis of free cash flow and valuation. We can't simply ignore that these 3 expenses in particular total to $9.3 million, and removing them from the equation, non-GAAP EBITDA is ~$5.9 million. Not to mention, it also recorded a $60 million payment to its parent organization. Therefore, whilst it converted $8.5 million in quarterly cash flow, this was more than offset by these expenditures. Exhibit 4. Non-GAAP EBITDA includes several expenditures that we argue should be included in cash flow analysis Data: AIRS 10-Q, Q2 FY2022 Valuation AIRS' growth strategy involves opening de novo centres, expanding existing ones and acquiring additional assets into its portfolio. In that regard, AIRS' corporate value stems from its popular set of procedures - particularly AirSculpt liposuction - as an intangible plus its tangible book value. Any value manager will also familiarize this information with cash flow multiples and forecasts.
Seeking Alpha • Aug 12

AirSculpt Technologies reports Q2 earnings beat; reaffirms FY22 guidance

AirSculpt Technologies press release (NASDAQ:AIRS): Q2 GAAP EPS of $0.01 beats by $0.01. Revenue of $49.7M (+42.1% Y/Y) beats by $4.79M. Same-center cases and revenue per case for the second quarter of 2022 were up 4.7% and 15.0%, respectively, over the prior year period. For the second quarter of 2022, the company’s adjusted EBITDA grew 7.1% to $15.2M as compared to $14.2M for the prior year period. The company is reiterating its revenue outlook of $175-179 million vs. consensus of $177.40M and its Adjusted EBITDA guidance in the range of $58 - $60 million. The Company has opened two centers in 2022 and anticipates opening two additional centers in the second half of the year.

주주 수익률

AIRSUS HealthcareUS 시장
7D11.0%-0.4%1.0%
1Y25.4%16.3%28.7%

수익률 대 산업: AIRS은 지난 1년 동안 16.3%의 수익을 기록한 US Healthcare 산업보다 더 좋은 성과를 냈습니다.

수익률 대 시장: AIRS은 지난 1년 동안 28.7%를 기록한 US 시장보다 저조한 성과를 냈습니다.

주가 변동성

Is AIRS's price volatile compared to industry and market?
AIRS volatility
AIRS Average Weekly Movement21.3%
Healthcare Industry Average Movement7.6%
Market Average Movement7.2%
10% most volatile stocks in US Market16.4%
10% least volatile stocks in US Market3.1%

안정적인 주가: AIRS의 주가는 지난 3개월 동안 US 시장보다 변동성이 컸습니다.

시간에 따른 변동성: AIRS의 주간 변동성(21%)은 지난 1년 동안 안정적이었지만 US 종목 중 상위 75%보다 높습니다.

회사 소개

설립직원 수CEO웹사이트
2012347Yogi Jashnaniwww.airsculpt.com

는 자회사와 함께 미국과 캐나다에서 바디 컨투어링 시술 서비스를 제공하는 EBS Intermediate Parent LLC의 지주회사로서 운영에 주력하고 있습니다. 이 회사는 최소 침습적 시술로 신체의 특정 부위를 조각하면서 지방을 제거하고 피부를 조여주는 바디 컨투어링 시술인 에어스컬프(AirSculpt)를 제공합니다. 또한 탁월한 정밀도와 정교함으로 지방을 영구적으로 제거하고 피부를 조여주는 시술인 에어스컬프트+와 고급 셀룰라이트 제거 도구인 에어스컬프트 스무스를 제공합니다.

AirSculpt Technologies, Inc. 기초 지표 요약

AirSculpt Technologies의 순이익과 매출은 시가총액과 어떻게 비교됩니까?
AIRS 기초 통계
시가총액US$371.07m
순이익 (TTM)-US$11.22m
매출 (TTM)US$151.84m
2.5x
주가매출비율(P/S)
-33.5x
주가수익비율(P/E)

AIRS는 고평가되어 있습니까?

공정 가치 및 평가 분석 보기

순이익 및 매출

최근 실적 보고서(TTM)의 주요 수익성 지표
AIRS 손익계산서 (TTM)
매출US$151.84m
매출원가US$51.53m
총이익US$100.31m
기타 비용US$111.53m
순이익-US$11.22m

최근 보고된 실적

Mar 31, 2026

다음 실적 발표일

해당 없음

주당순이익(EPS)-0.16
총이익률66.06%
순이익률-7.39%
부채/자본 비율44.7%

AIRS의 장기 실적은 어땠습니까?

과거 실적 및 비교 보기

기업 분석 및 재무 데이터 상태

데이터최종 업데이트 (UTC 시간)
기업 분석2026/05/22 11:55
종가2026/05/22 00:00
수익2026/03/31
연간 수익2025/12/31

데이터 소스

당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.

패키지데이터기간미국 소스 예시 *
기업 재무제표10년
  • 손익계산서
  • 현금흐름표
  • 대차대조표
분석가 컨센서스 추정치+3년
  • 재무 예측
  • 분석가 목표주가
시장 가격30년
  • 주가
  • 배당, 분할 및 기타 조치
지분 구조10년
  • 주요 주주
  • 내부자 거래
경영진10년
  • 리더십 팀
  • 이사회
주요 개발10년
  • 회사 공시

* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.

별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.

분석 모델 및 스노우플레이크

이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.

Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.

산업 및 섹터 지표

산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.

분석가 소스

AirSculpt Technologies, Inc.는 6명의 분석가가 다루고 있습니다. 이 중 2명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.

분석가기관
Michael GormanBTIG
Sam EiberBTIG
Benjamin MayoLeerink Partners LLC